|
?:abstract
|
-
In the COVID-19 era, among the main benefits that telemedicine provides to the neurosurgeon, we can mention that it allows the neurosurgeon to reach the patient remotely without being exposed to patients who could be positive for COVID-19;enables the neurosurgeon to use time more efficiently;facilitates the neurosurgeon to differentiate routine cases from neurosurgical emergencies and to decide a behavior;expedites preparation to receive and evaluate patients upon admission to hospital;and it allows the neurosurgeon monitor patients properly, e g , the postoperative controls, vascular pathology, and brain tumors, which lend themselves to easier evaluation through telehealth visits In the COVID-19 era, the main advantages offered by telemedicine for a patient are that it provides greater availability of health care for populations with inconveniences to receiving medical care, especially for specialized medical care such as neurosurgery;eliminates geographic barriers while adhering to COVID-19 safety guidelines;patients can avoid traveling (and being exposed to the virus);and reduces lost work due to hospital visits and reduces patient expenses Likewise, it allows patients to be adequately examined according to their symptomatology, along with their medical and surgical history, allowing them to be identified as potential candidates for surgical intervention or conservative treatment Current circumstances have encouraged more neurosurgeons to establish telemedicine as part of their daily practice, not only on the job side but also on the academic side, in the case of being a professor In this way, knowing the many benefits that telemedicine provides for both neurosurgeon and patients, we urge neurosurgical centers to take advantage of this alternative provided by technology and to educate patients in its correct use, to ensure their safety, to reduce the spread of severe acute respiratory syndrome coronavirus 2 among physician-patients, and to contribute to a decrease in global statistics
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}